e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
Fox Benjamin D., Shimony Avi, Langleben David, Hirsch Andrew, Rudski Lawrence, Schlesinger Robert, Eisenberg Mark J., Joyal Dominique, Hudson Marie, Boutet Kim, Serban Alexandrina, Masetto Ariel, Baron Murray
Source:
Eur Respir J 2013; 42: 1083-1091
Journal Issue:
October
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fox Benjamin D., Shimony Avi, Langleben David, Hirsch Andrew, Rudski Lawrence, Schlesinger Robert, Eisenberg Mark J., Joyal Dominique, Hudson Marie, Boutet Kim, Serban Alexandrina, Masetto Ariel, Baron Murray. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013; 42: 1083-1091
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015
Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012
High prevalence of COPD among adults with heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016
Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019
Unexpected high prevalence of left ventricular cardiopathy in patients with COPD
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010
Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 422-430
Year: 2015
Pulmonary hypertension in left heart disease
Source: Eur Respir Rev 2012 21: 338-346
Year: 2012
Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006
Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009
Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
High prevalence of undiagnosed COPD in patients with cardiovascular disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?
Source: Eur Respir J 2013; 42: 888-890
Year: 2013
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2011; 39: 112-118
Year: 2012
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2012; 39: 112-118
Year: 2012
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept